Results
|
|
41.
|
|
|
|
42.
|
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma. [electronic resource] by
- Sartore-Bianchi, Andrea
- Gasparri, Fabio
- Galvani, Arturo
- Nici, Linda
- Darnowski, James W
- Barbone, Dario
- Fennell, Dean A
- Gaudino, Giovanni
- Porta, Camillo
- Mutti, Luciano
Producer: 20071220
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13
Availability: No items available.
|
|
|
43.
|
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. [electronic resource] by
- Fennell, Dean A
- Parmar, Amit
- Shamash, Jonathan
- Evans, Marie T
- Sheaff, Michael T
- Sylvester, Richard
- Dhaliwal, Kevin
- Gower, Nicole
- Steele, Jeremy
- Rudd, Robin
Producer: 20050128
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|
|
|
44.
|
|
|
|
45.
|
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma. [electronic resource] by
- Fennell, Dean A
- McDowell, Cliona
- Busacca, Sara
- Webb, Glen
- Moulton, Brian
- Cakana, Andrew
- O'Byrne, Kenneth J
- Meerbeeck, Jan V
- Donnellan, Paul
- McCaffrey, John
- Baas, Paul
Producer: 20130117
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7
Availability: No items available.
|
|
|
46.
|
Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. [electronic resource] by
- Barbone, Dario
- Cheung, Priscilla
- Battula, Sailaja
- Busacca, Sara
- Gray, Steven G
- Longley, Daniel B
- Bueno, Raphael
- Sugarbaker, David J
- Fennell, Dean A
- Broaddus, V Courtney
Producer: 20130627
In:
PloS one vol. 7
Availability: No items available.
|
|
|
47.
|
|
|
|
48.
|
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study. [electronic resource] by
- Fennell, Dean A
- Myrand, Scott P
- Nguyen, Tuan S
- Ferry, David
- Kerr, Keith M
- Maxwell, Perry
- Moore, Stephen D
- Visseren-Grul, Carla
- Das, Mayukh
- Nicolson, Marianne C
Producer: 20150623
In:
PloS one vol. 9
Availability: No items available.
|
|
|
49.
|
Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2). [electronic resource] by
- Pillai, Rathi N
- Fennell, Dean A
- Kovcin, Vladimir
- Ciuleanu, Tudor-Eliade
- Ramlau, Rodryg
- Kowalski, Dariusz
- Schenker, Michael
- Yalcin, Ilker
- Teofilovici, Florentina
- Vukovic, Vojo M
- Ramalingam, Suresh S
Producer: 20200828
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|
|
|
50.
|
|
|
|
51.
|
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation. [electronic resource] by
- Hasan, Baktiar
- Greillier, Laurent
- Pallis, Athanasios
- Menis, Jessica
- Gaafar, Rabab
- Sylvester, Richard
- Fennell, Dean A
- Baas, Paul
- Surmont, Veerle
- Van Meerbeeck, Jan P
- O'brien, Mary E R
Producer: 20141208
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
|
52.
|
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion. [electronic resource] by
- Szlosarek, Peter W
- Klabatsa, Astero
- Pallaska, Arben
- Sheaff, Michael
- Smith, Paul
- Crook, Tim
- Grimshaw, Matthew J
- Steele, Jeremy P
- Rudd, Robin M
- Balkwill, Frances R
- Fennell, Dean A
Producer: 20071128
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 12
Availability: No items available.
|
|
|
53.
|
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. [electronic resource] by
- Barr, Martin P
- Gray, Steven G
- Hoffmann, Andreas C
- Hilger, Ralf A
- Thomale, Juergen
- O'Flaherty, John D
- Fennell, Dean A
- Richard, Derek
- O'Leary, John J
- O'Byrne, Kenneth J
Producer: 20130724
In:
PloS one vol. 8
Availability: No items available.
|
|
|
54.
|
Progress in the Management of Malignant Pleural Mesothelioma in 2017. [electronic resource] by
- McCambridge, Amanda J
- Napolitano, Andrea
- Mansfield, Aaron S
- Fennell, Dean A
- Sekido, Yoshitaka
- Nowak, Anna K
- Reungwetwattana, Thanyanan
- Mao, Weimin
- Pass, Harvey I
- Carbone, Michele
- Yang, Haining
- Peikert, Tobias
Producer: 20190417
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13
Availability: No items available.
|
|
|
55.
|
Reply to K. Masuda et al. [electronic resource] by
- Fennell, Dean A
- Taylor, Paul
- Gilligan, David
- Nakano, Takashi
- Scherpereel, Arnaud
- Pavlakis, Nick
- van Meerbeeck, Jan P
- Aerts, Joachim G J V
- Nowak, Anna K
- Kindler, Hedy
- Baas, Paul
Producer: 20200521
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 37
Availability: No items available.
|
|
|
56.
|
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. [electronic resource] by
- Busacca, Sara
- Sheaff, Michael
- Arthur, Kenneth
- Gray, Steven G
- O'Byrne, Kenneth J
- Richard, Derek J
- Soltermann, Alex
- Opitz, Isabelle
- Pass, Harvey
- Harkin, D Paul
- Quinn, Jennifer E
- Fennell, Dean A
Producer: 20120622
In:
The Journal of pathology vol. 227
Availability: No items available.
|
|
|
57.
|
RanGTPase: a candidate for Myc-mediated cancer progression. [electronic resource] by
- Yuen, Hiu-Fung
- Gunasekharan, Vignesh-Kumar
- Chan, Ka-Kui
- Zhang, Shu-Dong
- Platt-Higgins, Angela
- Gately, Kathy
- O'Byrne, Ken
- Fennell, Dean A
- Johnston, Patrick G
- Rudland, Philip S
- El-Tanani, Mohamed
Producer: 20130520
In:
Journal of the National Cancer Institute vol. 105
Availability: No items available.
|
|
|
58.
|
BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma. [electronic resource] by
- Busacca, Sara
- Chacko, Alex D
- Klabatsa, Astero
- Arthur, Kenneth
- Sheaff, Michael
- Barbone, Dario
- Mutti, Luciano
- Gunasekharan, Vignesh K
- Gorski, Julia J
- El-Tanani, Mohamed
- Broaddus, V Courtney
- Gaudino, Giovanni
- Fennell, Dean A
Producer: 20140122
In:
PloS one vol. 8
Availability: No items available.
|
|
|
59.
|
Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. [electronic resource] by
- Yuen, Hiu-Fung
- Chan, Ka-Kui
- Grills, Claire
- Murray, James T
- Platt-Higgins, Angela
- Eldin, Osama Sharaf
- O'Byrne, Ken
- Janne, Pasi
- Fennell, Dean A
- Johnston, Patrick G
- Rudland, Philip S
- El-Tanani, Mohamed
Producer: 20120801
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
60.
|
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial. [electronic resource] by
- Fennell, Dean A
- Kirkpatrick, Emma
- Cozens, Kelly
- Nye, Mavis
- Lester, Jason
- Hanna, Gerard
- Steele, Nicola
- Szlosarek, Peter
- Danson, Sarah
- Lord, Joanne
- Ottensmeier, Christian
- Barnes, Daniel
- Hill, Stephanie
- Kalevras, Mihalis
- Maishman, Tom
- Griffiths, Gareth
Producer: 20190314
In:
Trials vol. 19
Availability: No items available.
|